Answer
Dizziness, fatigue and somnolence have been reported with cabotegravir (Vocabria) injections and may affect driving or operating machinery, with the patient’s clinical status and Vocabria’s adverse reaction profile requiring consideration.
Sources for this answer
- Vocabria 600 mg prolonged-release suspension for injectionViiV Healthcare UK Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 11Document updated
Sources checked